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Abstract
Background: Chlorine dioxide (CD) gas has a potent antimicrobial activity at extremely low concentration and
may serve as a new tool for infection control occupationally as well as publicly. However, it remains unknown
whether the chronic exposure of CD gas concentration effective against microbes is safe. Therefore, long-term, low
concentration CD gas inhalation toxicity was studied in rats as a six-month continuous whole-body exposure
followed by a two-week recovery period, so as to prove that the CD gas exposed up to 0.1 ppm (volume ratio) is
judged as safe on the basis of a battery of toxicological examinations.
Methods: CD gas at 0.05 ppm or 0.1 ppm for 24 hours/day and 7 days/week was exposed to rats for 6 months
under an unrestrained condition with free access to chow and water in a chamber so as to simulate the ordinary
lifestyle in human. The control animals were exposed to air only. During the study period, the body weight as well
as the food and water consumptions were recorded. After the 6-month exposure and the 2-week recovery period,
animals were sacrificed and a battery of toxicological examinations, including biochemistry, hematology, necropsy,
organ weights and histopathology, were performed.
Results: Well regulated levels of CD gas were exposed throughout the chamber over the entire study period. No
CD gas-related toxicity sign was observed during the whole study period. No significant difference was observed in
body weight gain, food and water consumptions, and relative organ weight. In biochemistry and hematology
examinations, changes did not appear to be related to CD gas toxicity. In necropsy and histopathology, no CD
gas-related toxicity was observed even in expected target respiratory organs.
Conclusions: CD gas up to 0.1 ppm, exceeding the level effective against microbes, exposed to whole body in
rats continuously for six months was not toxic, under a condition simulating the conventional lifestyle in human.
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Background
Chlorine dioxide (CD), which is a water-soluble, yellow
gas at room temperature, exists as a relatively stable free
radical and is a very strong oxidant agent [1-3]. There-
fore, when dissolved in water, CD has a potent antimi-
crobial activity against bacteria and viruses in vitro [4-7].
Additionally, recent studies presented that the gas-phase
CD also has a potent antimicrobial efficacy [8-10]. In par-
ticular, it was reported that the low-concentration CD gas
at 0.03 ppm has a protective effect against influenza A
virus infection in mice [11]. Also, Ogata and Shibata
reported that low-level CD gas-releasing canisters placed
in a classroom decreased the absenteeism of schoolchil-
dren in the winter season, presumably because of prevent-
ing the occurrence of epidemic cold and influenza [12].
Furthermore, it was shown in a prospective cohort clinical
study that the extremely low concentration CD gas, such
as 0.01 ppm or 0.02 ppm, prevented against influenza-like
illness [13]. Other studies also revealed that the low-
concentration CD gas inactivated feline calicivirus (FCV),
a norovirus surrogate, which was attached to a glass sur-
face in the wet or dry state [14,15]. The concentrations of
CD gas in these studies were not greater than the 8-hour
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time-weighted average (TWA), which was defined as 0.1
ppm by the US Department of Labor’s Occupational
Safety and Health Administration (OSHA) [16]. These
results suggest that the low-level CD gas may be an effec-
tive measure to disinfect space where people live in or
gather at, such as houses, offices, airport buildings, and
hospitals, as long as the CD gas concentration is not toxic.
However, the toxicity of the low-level, gas-phase CD,
particularly the long-term toxicity, has not been well stu-
died. In few inhalation toxicity studies of CD gas, Paulet
and Desbrousses [17-19] used high concentration of CD
gas, such as 2.5 ppm or higher. Also, the CD gas expo-
sure period was not longer than 45 days. The longest-
term study was conducted by Dalhamn [20]. His study
showed a no observed adverse effect level (NOAEL) of
0.1 ppm in rats exposed to CD gas for 5 hours/day for 10
weeks. However, because the CD gas concentration dur-
ing the exposure period fluctuated widely between 0.05
ppm and 0.3 ppm, the value of this study is limited.
Therefore, it is currently strongly desired to study
whether toxic signs are revealed or not if CD gas, at 0.1
ppm or lower, is exposed to animals for a longer period
of time than that in Dalhamn’s study. Furthermore, the
results of a toxicity study, in which animals are exposed
to CD gas continuously for 24 hours, will be useful to
simulate the realistic human lifestyle. If safety is con-
firmed under these conditions, the low-level CD gas may
be used continuously for infection control in the environ-
ment where human beings are present.
Thus, the purpose of this study was to examine the pre-
sence or absence of toxic effects of low-concentration CD
gas up to 0.1 ppm, the level of which was precisely regu-
lated when the gas was exposed to rats continuously for a
longer term than that of previous studies, under the con-
dition of free access to chow and water, simulating the
ordinary human lifestyle. In summary, the rationale for
the exposure levels chosen in this study is on the basis of
previous studies including ours showing that the antimi-
crobial effect of CD gas was found from 0.01 ppm [13] to
0.03 ppm [11]. Consequently, we chose the CD gas levels
of 0.05 ppm and 0.1 ppm that cover these effective con-
centrations, still not exceeding 0.1 ppm that is the US
OSHA’s 8-hour TWA long-term permissible level.
Methods
Test animals and housing conditions
Male and female Sprague-Dawley Crl:CD (SD) rats,
approximately 5 weeks old, were obtained from Charles
River Laboratories Japan (Yokohama, Japan). Two ani-
mals of the same gender per cage were housed in animal
rooms which were maintained with 24 ± 3°C tempera-
ture, 50 ± 10% relative humidity, and 12 hour light/dark
cycle. The animals were given free access to CRF-1 diet
(Oriental Yeast, Tokyo, Japan) and tap water. They were
kept for 1 week for acclimation to the facility and quar-
antine prior to the start of the exposure period. All pro-
cedures were conducted in adherence to the National
Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Institu-
tional Animal Care and Use Committee of Hamri Cor-
poration, to which the execution of this study was
contracted.
Generation of CD Gas and inhalation exposure chamber
CD gas was obtained from an electrochemical system
[21]. Briefly, CD gas was generated by dissolving the elec-
trolytically-evolved product of potassium chloride into
sodium chlorite solution. The experimental set-up for
the exposure of CD gas to rats is shown in Figure 1. Her-
metic inhalation exposure chambers, each size of which
was 700 W × 1350D × 1600H mm, were made up with
stainless steel and transparent vinyl chloride plates. The
ventilation rate in the chamber was 30 times per hour.
To maintain even CD gas flow and homogenous CD gas
concentration in the chamber, five small-size (25 mm ×
25 mm × 10 mm) direct current electric fans with an air-
flow rate of 0.048 m3/min (F2510CT-12UCV, Shicoh
Engineering, Kanagawa, Japan) were placed in each
chamber. The rats of the same gender were housed as
two animals per stainless steel wire mesh cage in the
chamber. The CD gas concentration in the chamber was
Figure 1 A schematic diagram of the set-up of a CD gas
exposure chamber. CD gas discharged from the CD gas generator
shown at the left was mixed with air by an airfoil fan, then sent to
a mixing chamber and flown through a perforated, flow lamination
plate to yield an even, regulated concentration CD gas flow
throughout cages housing animals in the exposure chamber. A
probe of CD gas detector was placed in the middle of the chamber
to monitor the CD gas concentration continuously. The ventilation
rate in the chamber was 30 times per hour. In order to ensure the
even exposure of CD gat to rats, the position of cages were rotated
once weekly. In an experiment prior to the study, it was confirmed
that the existence of animals, chow, water, and excrements did not
affect the flowing CD concentration (data not shown). It was also
confirmed that the CD gas concentration was equal at the inlet and
at the outlet as well as at the center of the chamber (data not
shown).
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regulated by adjusting the electric current of the electro-
lysis, and was monitored continuously by a CD gas detec-
tor (CS-7 with a CDS-7 sensor, New Cosmos Electric,
Osaka, Japan). The CD gas monitoring device was cali-
brated once daily against a CD gas glass tube detector
(No. 23 M, Gastec, Kanagawa, Japan).
Experimental design
Three groups, each consisting of 16 male and 16 female
rats, were allocated by a stratified random sampling
method. Difference in the average body weight of each
group fell within ± 20%. These groups were either
exposed with CD gas of 0.05 ppm (low), 0.1 ppm (high)
or air only (control). The animals were exposed with CD
gas for 24 hours per day, 7 days per week for 6 months,
except for the time of laboratory animal care (measuring
body weight and filling chow and water once weekly, and
removing excreta twice weekly) which was conducted
within 30 min for each time. In order to eliminate posi-
tional differences of CD gas level in the exposure space,
cages housing rats were rotated within the chamber once
every week. At the end of exposure period, 10 males and
10 females in each group were sacrificed. The remaining
6 male and 6 female animals in each group were main-
tained for an additional 2-week recovery period during
which time they were exposed with only air.
Observations
During the exposure and recovery period, animals were
observed daily for mortality and signs of toxicity. Body
weights, as well as food and water consumptions, were
recorded once weekly.
Biochemistry and hematology
Before necropsy, animals were fasted for approximate 16
hours to avoid yielding turbid serum/plasma. Then, ani-
mals were euthanized with isoflurane, and blood was
drawn from the abdominal aorta. The collected blood
was analyzed for aspartate transaminase (AST), alanine
aminotransferase (ALT), gamma-glutamyl transpeptidase
(g-GTP), total protein (TP), albumin (ALB), ratio of albu-
min to globulin (A/G), blood glucose (BG), total choles-
terol (TC), triglyceride (TG), blood urea nitrogen (BUN),
interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-
a), creatinine (CRE), C-reactive protein (CRP), phos-
phorus (P), calcium (Ca), sodium (Na), potassium (K),
chloride (Cl), prothrombin time (PT), activated partial
thromboplastin time (APTT), red blood cell count (RBC),
white blood cell count (WBC), hemoglobin concentration
(Hb), hematocrit (HTC), platelet count (PLT), mean cor-
puscular hemoglobin (MCH), neutrophil differential (NE
%), eosinophil differential (EO%), basophil differential
(BA%), monocyte differential (MO%), and lymphocyte
differential (LY%). Bronchoalveolar lavage fluid (BALF)
was collected from the left alveolus with 1.0 ml phos-
phate-buffered saline, and analyzed for the migratory cell
count (BC) and the percent of white blood cell (WBC%).
Necropsy, organ weights and histopathology
After collecting the blood and the BALF, the brain, the
hypophysis, the eye, the thyroid, the thymus, the heart, the
aorta, the right lung, the trachea, the pharynx, the liver,
the spleen, the pancreas, the adrenal gland, the stomach,
the kidney, the small intestine, the large intestine, the
ovaries, the testes, the bladder, the femur and the nasal
cavity were removed from the animals, and were observed
macroscopically for signs of the toxicity. After the weight
of the brain, the liver, the spleen, the adrenal gland, the
ovaries and the testes was measured, all organs were fixed
in a 10% formalin solution containing the neutral phos-
phate-buffered saline. Subsequently, the right lung, the tra-
chea, the pharynx and the nasal cavity were embedded in
paraffin, stained with hematoxylin and eosin, and under-
went optical microscopy.
Statistical analysis
All results were expressed as the means ± standard devia-
tion. Two-way repeated-measures ANOVA tests were
used to compare the body weight as well as the food and
water consumptions of the CD gas-exposed groups with
that of the control group. Other parameters were ana-
lyzed with Dunnett’s test. The level of significance was
set at p < 0.05 or p < 0.01.
Results
CD Gas concentrations
CD gas concentrations in exposure chambers during the
entire exposure period are shown in Figure 2. In the low
concentration chamber, the chronological drift of mean
CD gas level in each week was between 0.047 ppm and
0.060 ppm, whereas the drift in the high concentration
chamber was between 0.075 ppm and 0.120 ppm. The
mean ± SD of CD gas concentration during the exposure
period for the low concentration chamber was 0.054 ±
0.007 ppm, and that for the high concentration chamber
was 0.103 ± 0.011 ppm.
Macroscopic observation, food and water consumption,
and body and relative organ weights
During all study periods, no mortality was observed, and
there were no sings of the CD gas-related toxicity in
daily observation. There were no statistically-significant
changes in the body weight during the exposure period
between the exposed and the control groups (p = 0.348
in male, p = 0.466 in female; Figure 3). Furthermore, no
statistically significant differences were observed in food
and water consumptions between the exposed and the
control rats (food consumption: p = 0.101 in male,
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p = 0.613 in female; water consumption: p = 0.848 in
male, p = 0.812 in female; Figure 4). With respect to the
relative organ weight, no statistically significant changes
were observed in male and female rats during the expo-
sure period (Table 1). Additionally, during the recovery
period, no significant relative organ weight changes
were observed either in male or female rats (data not
shown).
Biochemistry and hematology values
Some parameters in biochemistry and hematology tests
during the exposure period resulted in statistically sig-
nificant differences between the CD gas-exposed and
the control rats (Tables 2 and 3). Among these para-
meters, the changes in Ca and MO% for male rats and
BC for female rats were not dose-related, as the high
dose exposed group did not show a statistically signifi-
cant change. Although EO% obtained either from high
or low exposure male rats was significantly lower than
those obtained from the control rats, it was also not a
dose-related change. In the recovery period, no para-
meter observed was attributable to CD gas-related
changes (data not shown). There was a statistically sig-
nificant change in BUN in the high exposure female
rats.
Necropsy and histopathology
No signs of the toxicity were observed in all organs on
macroscopic necropsy examination. On the histopatho-
logical observation of putative target organs, such as the
nasal meatus, the nasal cavity, the pharynx, the trachea
Figure 2 Time course of changes in the concentration of CD
gas in each chamber. CD gas concentration in each chamber was
measured continuously throughout the exposure period for six
months. To avoid the Figure looking too busy, symbols show the
mean of weekly CD gas concentration (open square: control (air);
open circle: 0.05 ppm; closed circle: 0.1 ppm), and error bars
represent standard deviations. Throughout the exposure period for
six months, there was no tendency of increase or decrease of CD
gas concentration, and the fluctuation of the CD gas level was kept
within ± 25%, irrespective of the CD dose level. The mean ±
standard deviation of CD gas concentration during the exposure
period for the low concentration chamber was 0.054 ± 0.007 ppm,
and that for the high concentration chamber was 0.103 ± 0.011
ppm.
Figure 3 Body weight changes in rats exposed to CD gas.
Arrows represent the end of the exposure period and the start of
the recovery period. (A); Males, and (B); females. Symbols (open
square: control; open circle: 0.05 ppm, and closed circle: 0.1 ppm)
show the mean body weight and error bars represent the standard
deviation. The body weight of animals was measured once weekly.
The number of rats for calculating mean ± standard deviations was
16 during the exposure period and 6 during the recovery period.
There was no statistically significant change observed between the
CD gas-exposed group and the control group throughout the study
period.
Figure 4 Food and water consumptions of rats exposed to CD
gas. Arrows represent the end of the exposure period and the start
of the recovery period. (A); food consumption in males, (B); food
consumption in females, (C); water consumption in males, and (D);
water consumption in females. Symbols (open square: control; open
circle: 0.05 ppm, and closed circle: 0.1 ppm) show the mean of food
and water consumptions and the error bars represent standard
deviations. The measurement was performed once weekly. The
number of rats for calculating the mean ± standard deviations was
16 during the exposure period and 6 during the recovery period.
There was no statistically significant difference between the CD gas-
exposed group and the control group throughout the study period,
irrespective of the CD gas exposure concentration.
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and the bronchus, no aberrant findings attributable to
inflammation, such as mucosal asthenia, infiltration and
increase in the amebocytes, and increase in the folliculus
lymphaticus, were observed (data not shown). We
observed a large amount of hemosiderin in blood vessels
after the exposure period, and it was deposited to the
submucosa of pulmonary capillaries. However, since this
finding was observed both in the exposed group and the
control group, it was not attributable to the CD gas
exposure. Also, during the recovery period, no changes
between the exposed and the control group were
observed (data not shown). Macrophage propagation,
although it was mild, was found in a few rats during the
exposure period as well as the recovery period. How-
ever, because the propagation was also observed in a
few female control rats during the recovery period, the
Table 1 Relative Organ Weight (%) of Rats Exposed to CD Gas for 6 Months
Group Control Low High
Organ Male Female Male Female Male Female
Brain 0.36 ± 0.05 0.60 ± 0.06 0.34 ± 0.02 0.59 ± 0.04 0.38 ± 0.06 0.64 ± 0.07
Liver 2.50 ± 0.20 2.46 ± 0.19 2.43 ± 0.28 2.47 ± 0.15 2.47 ± 0.15 2.43 ± 0.26
Spleen 0.13 ± 0.01 0.17 ± 0.02 0.13 ± 0.01 0.16 ± 0.01 0.13 ± 0.01 0.16 ± 0.03
Adrenal gland (right) 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
Adrenal gland (left) 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
Testis (right) 0.29 ± 0.04 0.28 ± 0.05 0.32 ± 0.04
Testis (left) 0.30 ± 0.04 0.30 ± 0.02 0.32 ± 0.05
Ovary (right) 0.02 ± 0.01 0.01 ± 0.01 0.02 ± 0.01
Ovary (left) 0.02 ± 0.00 0.01 ± 0.01 0.02 ± 0.01
Each value represents mean ± standard deviation of 10 rats
Table 2 Biochemistry Values of Rats Exposed to CD gas for 6 Months
Group Control Low High
Analyte Male Female Male Female Male Female
AST (U/l) 115.3 ± 34.7 140.6 ± 64.3 99.6 ± 20.0 115.5 ± 21.8 99.7 ± 22.1 179.6 ± 178.5
ALT (U/l) 37.5 ± 10.5 55.7 ± 39.6 33.4 ± 7.5 38.1 ± 11.1 38.8 ± 15.7 82.8 ± 116.4
g-GTP (U/l) 1.0 ± 0.0 1.1 ± 0.3 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0
TP (g/dl) 6.2 ± 0.2 7.3 ± 0.6 6.0 ± 0.4 7.3 ± 0.4 6.2 ± 0.2 7.2 ± 0.6
ALB (g/dl) 2.3 ± 0.1 3.0 ± 0.3 2.2 ± 0.1 3.1 ± 0.2 2.3 ± 0.1 3.1 ± 0.3
A/G 0.58 ± 0.03 0.72 ± 0.07 0.58 ± 0.04 0.74 ± 0.04 0.60 ± 0.04 0.76 ± 0.06
BG (mg/dl) 137.4 ± 11.3 137.1 ± 24.6 135.3 ± 27.6 131.2 ± 14.7 132.7 ± 13.0 129.2 ± 16.3
TC (mg/dl) 75.2 ± 14.2 87.5 ± 26.2 67.3 ± 18.2 101.6 ± 23.0 76.2 ± 16.0 88.5 ± 29.3
TG (mg/dl) 71.0 ± 19.4 84.4 ± 50.1 61.1 ± 21.9 118.6 ± 65.7 64.9 ± 32.9 69.1 ± 36.0
BUN (mg/dl) 14.1 ± 2.1 13.1 ± 1.6 14.0 ± 1.9 13.6 ± 2.3 15.4 ± 2.1 15.2 ± 0.9*
CRE (mg/dl) 0.33 ± 0.03 0.38 ± 0.05 0.33 ± 0.05 0.35 ± 0.02 0.36 ± 0.03 0.36 ± 0.02
CRP (mg/dl) 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00
P (mg/l) 6.3 ± 0.4 5.8 ± 0.4 6.2 ± 0.5 5.3 ± 0.7 6.2 ± 0.4 6.1 ± 0.8
Ca (mg/l) 10.3 ± 0.31 1.2 ± 0.6 9.9 ± 0.2* 11.0 ± 0.2 10.3 ± 0.3 11.2 ± 0.6
Na (mEq/l) 143.6 ± 1.0 141.6 ± 1.5 143.5 ± 1.5 141.5 ± 1.5 143.7 ± 0.9 142.0 ± 1.2
K (mEq/l) 4.6 ± 0.2 4.8 ± 0.6 4.7 ± 0.2 4.4 ± 0.3 4.6 ± 0.2 4.6 ± 0.6
Cl (mEq/l) 104.6 ± 1.4 102.6 ± 2.4 105.1 ± 0.7 102.2 ± 1.2 103.9 ± 1.7 102.1 ± 2.0
PT (sec) 15.9 ± 2.0 10.6 ± 0.6 15.0 ± 1.6 10.7 ± 0.7 15.6 ± 1.7 11.6 ± 3.2
APTT (sec) 22.7 ± 3.1 24.9 ± 6.0 20.6 ± 2.1 22.5 ± 3.1 21.1 ± 2.3 24.0 ± 12.5
IL-6 (pg/ml) ND ND ND ND 63.8 ± 24.1 ND
TNF-a (pg/ml) ND ND ND ND ND ND
Each value represents mean ± standard deviation of 10 rats
* Significantly different from control, p < 0.05
ND: Not detected (below the lower quantification limit: TNF-a; < 12.5 pg/ml, IL-6; < 62.5 pg/ml)
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finding was thought to be a common phenomenon. An
increase in amebocytes was observed in a few rats both
in the exposed and control group, therefore the finding
was not regarded as CD gas exposure-related.
Discussion
The results of our study demonstrate that there was no
significant toxicity of low-level CD gas, not greater than
0.1 ppm, following 24 hours/day, 7 days/week and 6-
months whole body exposure in rats. This exposure
period was longer than that of other previously reported
studies [17-20]. Additionally, we successfully regulated
the CD gas concentration within ± 25% of the target
concentration throughout the exposure period, in com-
parison with Dalhamn’s study in which actual CD gas
levels fluctuated widely between 0.05 ppm and 0.3 ppm
against the target concentration of 0.1 ppm [20].
According to the US OSHA, the long-time (8 hour)
permissible exposure TWA level of CD gas in environ-
mental air in a human workplace is 0.1 ppm. Our
results support that this level is not toxic in rats, even if
the exposure was continued for 24 hours. Also, in an
experiment before the study, we confirmed that the
existence of animals, chow, water and excreta did not
affect the circulating CD gas concentration under our
experimental condition, presumably because of the high
cycle time of ventilation, i.e., 30 times per hour (data
not shown). Moreover, we confirmed prior to the study
that the CD gas level was equal in the chamber and in
the cage, irrespective of where in the chamber it was
measured.
Because of the inhalation exposure of the oxidant
agent, it was expected that the primary target organs
would be the respiratory organs. However, there were
no significant changes of WBC in the blood and the
BALF. Also, the cytokines (TNF-a and IL-6), which
increase in the presence of inflammation [22,23], were
almost not detectable (Table 2), below the lower quanti-
fication limit (TNF-a: < 12.5 pg/ml; IL-6: < 62.5 pg/ml).
In the high exposure group of male rats, IL-6 was
detectable (63.8 pg/ml). However, this value was near
the lower quantification limit level. Additionally, in the
histopathological observation, no signs of toxicity in the
nasal meatus, the nasal cavity, the pharynx, the trachea
and the bronchus were observed. Thus, we concluded
that the whole body exposure of CD gas, not greater
than 0.1 ppm for 24 hours/day, 7 days/week for 6
months, did not cause the inflammatory sign in the
respiratory organs in rats.
In biochemistry and hematology examinations, we
observed that some parameters showed statistically sig-
nificant changes. However, almost all of the changes in
these parameters were not dose-related. EO%, which
was reported to increase as a result of allergy, such as
asthma or infection of parasitic arthropods [24-27],
showed a statistically significant change between the
exposed and the control groups. However, it was not a
dose-dependent change, and decreased in the exposed
group compared with the control group. To our specu-
lation, since the presumable mechanism of action of CD
is oxidation that is a physicochemical reaction, it’s toxi-
city, if any, should appear in a dose-dependent manner.
Table 3 Hematology and BALF Values of Rats Exposed to CD Gas for 6 Months
Group Control Low High
Analyte Male Female Male Female Male Female
Blood Cell Counts
RBC (102/μl) 1108 ± 85 942 ± 124 1039 ± 111 834 ± 72 1019 ± 117 881 ± 130
WBC (104/μl) 89 ± 20 62 ± 15 94 ± 29 56 ± 18 92 ± 21 63 ± 22
Hb (g/dl) 18.1 ± 1.4 16.8 ± 1.8 17.5 ± 2.2 15.2 ± 1.3 17.1 ± 2.0 16.8 ± 2.6
HTC (%) 54.4 ± 3.8 49.5 ± 5.9 52.1 ± 6.6 44.6 ± 4.0 51.7 ± 6.4 47.3 ± 7.5
PLT (104/μl) 78.4 ± 18.0 92.4 ± 18.7 85.5 ± 20.9 90.9 ± 18.7 93.2 ± 31.2 81.2 ± 19.5
MCH (pg) 16.3 ± 0.4 17.9 ± 0.6 16.8 ± 0.6 18.3 ± 0.8 16.8 ± 0.7 18.3 ± 0.9
NE% (%) 14.9 ± 5.8 12.5 ± 6.5 10.4 ± 3.1 13.7 ± 3.5 17.1 ± 4.8 17.5 ± 6.3
EO% (%) 0.9 ± 0.6 1.2 ± 0.9 0.2 ± 0.4* 0.7 ± 0.6 0.3 ± 0.3* 1.1 ± 0.6
BA% (%) 0.5 ± 0.6 0.5 ± 0.5 0.5 ± 0.4 0.8 ± 0.3 0.5 ± 0. 30.2 ± 0.3
MO% (%) 12.2 ± 4.2 12.5 ± 3.5 8.8 ± 2.4* 13.7 ± 3.0 11.5 ± 4.8 13.1 ± 6.3
LY% (%) 69.3 ± 7.9 71.9 ± 6.6 75.4 ± 5.3 67.9 ± 6.3 68.5 ± 4.8 66.2 ± 8.9
BALF Cell Counts
BC (104/ml) 39.4 ± 45.1 12.5 ± 10.0 27.1 ± 37.6 39.9 ± 18.1* 21.8 ± 13.1 28.4 ± 23.5
WBC% (%) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Each value represents mean ± standard deviation of 10 rats
* Significantly different from control, p < 0.05
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Thus, we concluded that the statistically significant
change of EO% was not a sign of CD gas-related toxi-
city. There was a statistically significant change in BUN
in the high exposure female rats. However, according to
a report of Charles River Laboratories Japan for SD rats
[28], mean ± standard deviation of BUN value in 30-
week old SD rats were 16.9 ± 1.9 mg/dl. Also, the mean
values in the control and low exposure groups were
lower than the reference range. Thus, we concluded that
the BUN value in the high exposure female rats was
within the normal range and was not a toxic sign.
In previous studies, LOAEL of 2.5 ppm for 30 days’
exposure [17], LOAEL of 1 ppm for two months [18],
NOAEL of 5 ppm and LOAEL of 10 ppm for 4 weeks
[19], and NOAEL of 0.1 ppm for 10 weeks and LOAEL
of 10 ppm for 2 weeks [20], all studied in rats, were
reported. However, since our primary objective in this
study was to reveal that the CD gas up to 0.1 ppm (the
concentration that exceeds the effective level against
microbes) was safe, even after the longest period of expo-
sure time. Therefore, although we should admit that we
were unable to determine the ordinary NOAEL and/or
LOAEL levels, our study was still valuable in terms of
confirming that the CD gas concentration that was effec-
tive against microbes was not toxic.
It was reported that CD gas at a low concentration pre-
vented an infectious respiratory disease in vivo, and also
inactivated feline calicivirus, influenza A virus, Staphylo-
coccus aureus and Escherichia coli in vitro [11-15].
According to these studies, effectiveness of CD gas was
shown below 0.1 ppm. Hence, our study results suggest
that the protective level of CD gas against infectious
agents may not be a toxic level in rats, therefore the con-
tinuous exposure of a low level CD gas not greater than
0.1 ppm may have a possibility to be an effective measure
to disinfect spaces where people live in or gather at, such
as houses, offices, airport buildings and hospitals,
although some uncertainty factors, such as inter-species
differences and inter-individual variations, should be
taken into account. Furthermore, a higher dose(s) may
have to be employed so as to define the LOAEL as well
as NOAEL. Also, additional toxicity studies, such as a
developmental toxicity study and a reproduction toxicity
study, will be necessary to warrant the safety of continu-
ous exposure of low-level CD gas in public space for the
purpose of controlling infection from various, airborne
and surface-residing microorganisms.
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